Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1 Human Recombinant ( LYVE1 Human )

Data sheet

Formulation

LYVE-1 Human Recombinant protein at 100ug/ml in 50mM Tris-Acetate, pH7.5, 1mM EDTA and 20% Glycerol.

Purity

Greater than 90.0% as determined by(a)Analysis by RP-HPLC.(b)Analysis by SDS-PAGE.

Description

Soluble LYVE1 Human Recombinant fused to a GST-tag produced in E.Coli is a single, non-glycosylated, polypeptide containing 243-323 amino acids and having a total molecular mass of 36 kDa. The LYVE-1 is purified by proprietary chromatographic techniques.

Protein Background

LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. The deduced amino acid sequence of LYVE-1 predicts a 322-residue type I integral membrane polypeptide 41% similar to the CD

Expression host

Escherichia Coli.

Synonyms

Lymphatic vessel endothelial hyaluronic acid receptor 1 precursor, LYVE-1, Cell surface retention sequence-binding protein 1, CRSBP-1, Hyaluronic acid receptor, Extracellular link domain-containing protein.

Reagent Appearance

Sterile Filtered colorless solution.

Stability

LYVE-1 although stable at 15°C for 1 week, should be stored desiccated below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Please prevent freeze-thaw cycles.